Sr. Director – Enterprise Pandemic Preparedness and Response

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve.

This is hard, urgent, selfless work—but it's work worth doing. If you're driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

The Sr. Director, Pandemic Preparedness and Response serves as Lilly's enterprise leader responsible for pandemic preparedness, infectious disease risk management, and public health emergency response strategy. This role establishes the governance, policies, and cross‑functional capabilities necessary to protect employees, ensure continuity of clinical development and manufacturing operations, safeguard global supply chains, and sustain patient access to critical medicines during infectious disease outbreaks and pandemics.

Working across Lilly Research Laboratories, Manufacturing, Supply Chain, Global Security, Corporate Affairs, Occupational Health, Medical Affairs, Clinical Development, and Human Resources, this leader drives enterprise readiness and response efforts, advises executive leadership on emerging biological threats, and represents Lilly with governmental, regulatory, industry, and public health organizations. The Sr. Director serves as Lilly's advisor on pandemic preparedness and enterprise health security, ensuring the company maintains the capabilities, partnerships, and operational resilience necessary to respond to future infectious disease threats while supporting the development, manufacture, and delivery of medicines and vaccines that address global public health needs.

During significant public health emergencies, this role serves as a key member of enterprise crisis leadership structures and provides strategic leadership for company‑wide response activities. This role reports to the VP/Chief Scientific Officer, Infectious Disease.

• Own Lilly's enterprise pandemic preparedness and infectious disease response strategy, establishing policies, standards, governance processes, and readiness expectations across all major business functions.
• Advise the Executive Committee and senior leadership on emerging infectious disease threats, preparedness investments, and outbreak‑related business risks.
• Establish enterprise preparedness objectives, performance metrics, and readiness assessments to ensure organizational resilience.
• Lead development and continuous improvement of enterprise‑wide pandemic and infectious disease response plans covering R&D, clinical development, manufacturing, supply chain operations, commercial activities, and corporate functions.
• Prepare strategic briefings, recommendations, and risk assessments for executive leadership, governance committees, and the Board.

• Oversee monitoring of global infectious disease surveillance data, epidemiological intelligence, and public health advisories from organizations including WHO, CDC, ECDC, and other relevant authorities.
• Translate emerging outbreak signals into business‑relevant risk assessments and strategic recommendations affecting employees, facilities, supply chains, clinical trials, and patient access.
• Lead enterprise assessments of pandemic‑related vulnerabilities across manufacturing facilities, supplier networks, clinical trial operations, and critical business…